About Us
Home
Committee
ITS Consitution
Journal
Guidelines
Practice Guidelines
Join ITS
Events
All Events
Quiz
ITSCON 2023
Announcements
Research Grant
Thyroid Nodule Survey
PG Trainee Grant 2022
Election Notice 2023
Contact Us
Login
MEMBER LOGIN
Email/Mobile
Membership No
LM-
Login
ITS - Thyroid Nodule Survey
Basic Details
Your Email ID
*
1. Select what best describes you
*
--Select--
Endocrinologist
Surgeon
Physician interested in endocrinology
Nuclear medicine specialist
Radiologist
Other
2. Which one of the following best describes your practice?
*
--Select--
Academic Medical Center
Corporate multi specialty hospital
Ambulatory clinic (single or multi specialty clinic)
Nuclear medicine specialist
Secondary care hospital (Private or Public)
Other
3. Please state the geographic location in which you practice
*
--Select--
India
Other South Asian Country
South East Asia
Korea
Japan
United States
Continental Europe
Middle East
Africa
China
Taiwan
Other
4. Do you take care of patients with nodular thyroid disease
*
--Select--
Yes
No
Imaging
5. Which one of the following best represents your initial approach to a patient with a solitary thyroid nodule and normal TSH?
*
--Select--
Ultrasound (USG) thyroid
CT or other imaging
Nuclear medicine scan (Technetium 99m or Iodine)
Fine needle aspiration cytology
Additional imaging
6. If the answer to question 5 was NOT Ultrasound thyroid which one of the following best describes your next step
*
--Select--
USG thyroid
FNAC
Other
Ultrasound scoring system
7. Do you perform the Ultrasound yourself
*
--Select--
Yes
No
8. Do you use a scoring system for thyroid ultrasound
*
--Select--
Yes
No
9. Which USG based scoring system do you use
--Select--
ACR TIRADS
ATA risk score
AI enabled TIRADS scoring
Older versions of TIRADS or country specific TRIADS
Other
10. Please provide reasons for use of the scoring system
*
Familiarity
Reporting practice of radiologist
Best suited to my practice based on evidence
Other
FNAC
11. Which of the following best describes your choice of patient for a Fine needle aspiration cytology
*
--Select--
All patients irrespective of USG finding or scoring system
Based on the size and score criteria recommended for the USG scoring system
Intermediate or high risk group identified by the scoring system irrespective of size
Proceed with surgery based on clinical and USG estimation of risk
12. In patients with low risk feature of malignancy (eg ACR TIRADS 2) on USG which one of the following best describes your practice
*
--Select--
USG guided FNAC in all patients
Periodic USG follow up
USG guided FNAC if they meet a certain size criteria
No further follow up
13. In patients with intermediate or high risk features of malignancy (eg ACR TIRADS 4 or above) with sub centimetric dimensions which one of the following best describes your practice
*
--Select--
USG guided FNAC in all patients
USG follow up with FNAC if any of the dimensions are > 1 cm
Surgery
Other
Cytology
14. In patients with low risk cytology (bethesda 2) which one of the following best describes your practice
*
--Select--
No further testing or follow up
Periodic follow up with clinical exam and or USG with repeat aspiration ONLY if there is a significant increase in size or risk score
Periodic follow up with clinical exam and or USG AND repeat aspiraton
Surgery
15. In patients with indeterminate cytology (bethesda 3 or 4) which one of the following best describes your approach
*
--Select--
Surgery in all patients
Decision on surgery based on molecular markers (eg affirma etc)
Second opinion on cytopathology and correlation with ultrasound
Reaspirate after a specified interval
16. Optional space for comment explanations etc.
*
Submit
Notify Me
Subscribe
Facebook
Notify me about events & activities
Name
Email Id.
Mobile No.
Submit
